Salg af egne aktier
December 08, 2023 07:32 ET
|
ORPHAZYME A/S
Som omtalt i selskabsmeddelelse nr. 24/2023 erhvervede selskabet 3.212 egne aktier i forbindelse med gennemførelsen af det omvendte aktiesplit. På den seneste ekstraordinære generalforsamling, jf....
Resultat af omvendt aktiesplit
December 08, 2023 06:07 ET
|
ORPHAZYME A/S
Som omtalt i selskabsmeddelelse nr. 18 og 19/2023 iværksatte selskabet en proces om omvendt aktiesplit med det formål, at reducere selskabets omkostningsbase, da mere end 80 % af selskabets aktionærer...
Finanskalender 2024
November 30, 2023 05:05 ET
|
ORPHAZYME A/S
Vedhæftet er oversigt over selskabets finanskalender for 2024. Onsdag den 20. marts 2024Årsrapport 2023Torsdag den 11. april 2024Ordinær generalforsamlingTirsdag den 14. maj 2024Periodemeddelelse for...
Minutes of the Extraordinary General Meeting of Orphazyme A/S
November 30, 2023 05:01 ET
|
ORPHAZYME A/S
An extraordinary general meeting was held in Orphazyme A/S, company reg.no. 32266355 (the “Company”) on Thursday, 30 November at 10:00 (AM) at the Company’s address at Lyskjær 8A, 2730 Herlev Agenda:...
Notice of Extraordinary General Meeting in Orphazyme A/S
November 08, 2023 12:28 ET
|
ORPHAZYME A/S
The board of directors hereby convenes for an extraordinary general meeting in Orphazyme A/S at the company’s address at Lyskjær 8A, 2730 Herlev on Thursday 30 November 2023 at 10.00 AM (CET). ...
Business update October 2023
November 08, 2023 12:23 ET
|
ORPHAZYME A/S
Unless otherwise stated, comments in this announcement refer to performance from continuing operations from 1 January – 31 October 2023. Net loss for the 10 months ended October 2023 totaled DKK 29...
Process for reverse share split at a consolidation ratio of 1.000:1
November 02, 2023 05:42 ET
|
ORPHAZYME A/S
At the company’s extraordinary general assembly November 2nd 2023 it was decided to implement a reverse share split at a consolidation ratio of 1.000:1, see company announcement 18/2023. The reverse...
Decisions of extraordinary general assembly
November 02, 2023 05:35 ET
|
ORPHAZYME A/S
The company convened its extraordinary general assembly today November 2nd 2023 10.00 AM (CEST) at its office address, Lyskær 8A, 2730 Herlev, see company announcement 17/2023 for the full...
Notice convening the Extraordinary General Meeting of Orphazyme A/S
October 11, 2023 04:58 ET
|
ORPHAZYME A/S
The Board of Directors hereby convenes an Extraordinary General Meeting to be held at the Company’s address at Lyskjær 8A, 2730 Herlev on Thursday November 2nd 2023 at 10:00 AM (CEST). Agenda: ...
Notice of proposal to Consolidate Shares in Orphazyme A/S
October 11, 2023 04:53 ET
|
ORPHAZYME A/S
As described in Company Announcements 12/2023, the strategy for Orphazyme is to optimize the cost structure of the company, while the search for a new activity is ongoing. To reduce the running...